Preoperative cardiovascular risk factor control in elective coronary artery bypass graft patients: a failure of

Roger J F Baskett1, Karen J Buth, Cherie Collicott

  • 1Dalhousie University and the Maritime Heart Centre, Queen Elizabeth II Health Sciences Centre, Halifax, Canada. RoberBaskett@hotmail.com

Insights

Cardiovascular risk factor control is crucial for patients undergoing coronary artery bypass graft (CABG) surgery. Despite treatment, management of conditions like hypertension and diabetes remains inadequate, highlighting a need for improved long-term strategies and patient education.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Patients undergoing coronary artery bypass graft (CABG) face significant risks of disease progression and cardiac events.
  • Effective cardiovascular risk factor control is essential for reducing mortality and subsequent clinical events in this population.
  • The adequacy of cardiovascular risk factor management in CABG patients remains an under-researched area.

Purpose of the Study:

  • To assess the prevalence of modifiable cardiovascular risk factors in patients scheduled for elective CABG.
  • To evaluate the existing treatments for these risk factors.
  • To determine the adequacy of risk factor control based on established guidelines.

Main Methods:

  • A cohort of 120 patients undergoing elective CABG was studied over six months.
  • Key risk factors assessed included smoking, hypertension, hypercholesterolemia, obesity, and diabetes.
  • Control adequacy was evaluated against published consensus conference guidelines.

Main Results:

  • While 95% of patients received treatment, control was poor: only 20/86 for hyperlipidemia, 10/36 for diabetes, and 56/82 for hypertension.
  • High prevalence of current smokers (21/120) and obesity (78/120) was observed.
  • Only 13% of patients had all assessed risk factors adequately controlled.

Conclusions:

  • The prevalence of cardiovascular risk factors in CABG patients is very high.
  • Despite high treatment rates, risk factor management is largely inadequate.
  • Enhanced long-term management, patient education, and motivation are critical for improving outcomes post-CABG.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...